TECH & INNOVATIONBatteries are known to pollute the environment from mining to residue. Click to learn more about Tesla's new nickel-based battery that can allegedly last up to a hundred years in ideal conditions.
Are you having trouble correcting your posture? Read and discover how a newly developed self-powered fabric paired with sensors may help solve your problem.
SpaceX CEO Elon Musk contends one could fit all the DNA sequences of humans in a small data storage system. Read on and learn more about the possibilities.
US-based Good Meat announced that it will be building the world's largest bioreactors that will produce lab-grown meat. Read on to learn further details about this "gamechanger" in the nascent industry.
A new study shows the emotional reaction of adults after interacting with a humanoid robot. Find out how this new approach helps enhance seniors’ mental health.
Scientists have developed a small new gel film that can squeeze out up to 13 liters of water from the thin air each day. How can this be possible? Find out.
Titanium is usually used in the field of medicine, in particular for dental implants. Read this article to understand why the titanium implant is the preferred choice as we discuss its biocompatibility.
Researchers introduced a new technique to create pixelated sheets that will quickly produce soft robotic devices. Read and find how more about the technology.
SARS-CoV-2 test may soon fight the pandemic. Find out how the use of fecal samples from bats potentially contributes to the control of the spread of viruses.
BRIM Biotechnology, Inc. ("BRIM") a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. ("ORA") the world's leading, ophthalmic research organization, for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM intends to initiate Phase 3 clinical studies with Ora's support later this year.